Article

Immunohistochemical localization of advanced glycation end products in pinguecula

Department of Ophthalmology, University of Tsukuba, Tsukuba, Ibaraki, Japan
Albrecht von Graæes Archiv für Ophthalmologie (Impact Factor: 2.33). 02/2006; 244(1):104-8. DOI: 10.1007/s00417-005-0047-y
Source: PubMed

ABSTRACT Advanced glycation end products (AGEs) are known to be deposited in the target organ of ageing. In addition, the deposition of AGEs accelerate the process of ageing. We investigated the immunohistochemical localization of AGEs in pinguecula, one of the ocular changes related with ageing process.
Surgical specimens of conjunctiva with or without pinguecula were prepared from nine patients, respectively. Immunohistochemical localization of AGEs was investigated using monoclonal antibodies to N(epsilon)-(carboxymethyl)lysine, pentosidine, imidazolone, and pyrraline.
Moderate to strong immunoreactivities to AGEs were detected in the subepithelial amorphous deposits of all the surgical specimens with pinguecula. In contrast, no or weak immunoreactivities to AGEs were detected in the surgical specimens without pinguecula.
Pinguecula is an aggregation of AGEs-modified proteins. The presence of pinguecula would be an index of local irradiation of ultraviolet rays and decreased antioxidant activities.

0 Followers
 · 
91 Views
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Climatic droplet keratopathy (CDK), known as spheroid degeneration of the cornea, is one of the most frequent degenerative corneal disorders affecting visual function. However, the histochemical nature of the deposits seen in CDK is still unclear. To investigate the pathogenesis of CDK, we investigated the immunohistochemical localisation of advanced glycation end products (AGEs) in surgical specimens of CDK. Immunohistochemical localisation of N(epsilon)-(carboxymethyl)-l-lysine (CML), N(epsilon)-(carboxyethyl)-l-lysine (CEL), pyrraline, pentosidine and imidazolone was examined in three corneas with CDK, six corneas with bullous keratopathy and three corneas without any corneal diseases. In all the specimens with CDK, immunoreactivity was strong in CML, moderate in pyrraline and pentosidine, and weak in imidazolone. Immunoreactivity was absent in CEL. In contrast, no immunoreactivity to CML, pyrraline, pentosidine, imidazolone or CEL was detected in corneas with bullous keratopathy, or in corneas without any corneal diseases. CDK is caused by an aggregation of AGE-modified proteins. The result is consistent with etiological findings that ultraviolet irradiation and ageing, both of which are accelerators of AGE formation, are closely related to the development of CDK.
    British Journal of Ophthalmology 02/2007; 91(1):85-8. DOI:10.1136/bjo.2006.099812 · 2.81 Impact Factor
  • Journal of the American Academy of Dermatology 08/2007; 57(1):177-8. DOI:10.1016/j.jaad.2007.03.037 · 5.00 Impact Factor
Show more

Preview

Download
0 Downloads
Available from